Xalkori 200 mg
Xalkori 200 mg is a medicine authorised by Swissmedic under authorisation number 62131. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 05 March 2012 and the authorisation is valid without a time limit. ATC code L01ED01 places the medicine in the group Antineoplastic agents.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Xalkori 200 mg, Hartkapseln | A | 05 March 2012 |
| 2 | Xalkori 250 mg, Hartkapseln | A | 05 March 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Kapsel(n) | L01ED01 | 07.16.1. | A |
| 3 | 60 | Kapsel(n) | L01ED01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Xalkori 200 mg authorised in Switzerland?
Yes. Xalkori 200 mg is authorised by Swissmedic under authorisation number 62131, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Xalkori 200 mg have?
Xalkori 200 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Xalkori 200 mg?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.